ReviewCancers2022

Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer.

Andrisha-Jade Inderjeeth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.